PROCLAIMING MAY 2026, TO BE "ALS AWARENESS MONTH" IN THE STATE OF, RHODE ISLAND
S3305 is a Senate resolution that proclaims May 2026 as "ALS Awareness Month" in Rhode Island. The resolution describes amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, as a progressive and fatal neurodegenerative disease that affects a person’s ability to walk, talk, eat, and breathe, and it cites national and global prevalence, survival rates, and the lack of a cure.
The resolution emphasizes the importance of public awareness, access to therapies and durable medical equipment, communication technologies, and clinical trials for people living with ALS. It also highlights the elevated risk of ALS among military veterans, notes that the U.S. Department of Veterans Affairs recognizes ALS as service-connected, and acknowledges the work of the ALS Association and ALS United RI. The measure directs the Secretary of State to send a certified copy of the resolution to ALS United RI and urges Rhode Islanders to educate themselves and support efforts to combat the disease.
As a ceremonial resolution, S3305 does not amend Rhode Island statutes, create regulatory requirements, or appropriate funds. Its legal effect is limited to officially designating May 2026 as ALS Awareness Month and authorizing transmission of the resolution to ALS United RI, while serving as a public statement of legislative support for ALS awareness and research.
The tone of the resolution is strongly supportive and commemorative, with no recorded opposition, committee controversy, or vote history in the provided materials. The bill frames ALS as a serious public health issue and expresses sympathy for affected individuals, support for caregivers and researchers, and encouragement for public education and advocacy.
No notable points of contention appear in the available record. Because the measure is a nonbinding awareness resolution, it is unlikely to have generated policy disputes over implementation or cost. The only substantive themes are recognition of ALS as a devastating disease, the importance of research and treatment access, and the special impact on veterans, all of which are presented in a supportive rather than contested manner.